Clik here to view.
ADDING MULTIMEDIA Samsung Collaboration with Kaiser Permanente Delivers...
SEOUL, South Korea Samsung Electronics Co., Ltd. revealed the results of a joint cardiac rehabilitation initiative, developed in collaboration with Kaiser Permanente, the largest not-for-profit...
View ArticleClik here to view.
Japanese Companies Should Not Miss out Opportunities from Rapidly Growing...
TOKYO ASEAN is facing rapid population ageing. It is estimated that all ASEAN countries will become ageing society (more than 7% of the population is 65 years old or older) in 20 years. Singapore...
View ArticleClik here to view.
Clik here to view.
Invicro任命Hidenori Seshimo先生为日本生物标记物服务副总裁
波士顿 (美国商业资讯)–Invicro LLC隶属于柯尼卡美能达公司(Konica Minolta)，是一家领先的影像学生物标记物、核心实验室服务和研究及药物开发软件提供商。该公司今天宣布，任命工程学硕士Hidenori Seshimo先生为日本生物标记物服务副总裁。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
Dr. Reddy’s Laboratories announces the launch of Bupropion Hydrochloride...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the...
View ArticleClik here to view.
P&G, National Geographic and Global Citizen Launch Groundbreaking Series,...
CINCINNATI Procter & Gamble and National Geographic’s six-part docuseries ACTIVATE, co-produced by Global Citizen and RadicalMedia, premieres tonight, Thursday, September 5, in the U.S. on...
View ArticleClik here to view.
Usona Institute Clinical Trial of Psilocybin for Major Depressive Disorder...
MADISON, Wis. Usona Institute launches its Phase 2 study of psilocybin for major depressive disorder this fall. The study, PSIL201, will be conducted at seven U.S. sites and will investigate the...
View ArticleClik here to view.
AVITA Medical Added to the S&P/ASX 300 Index
VALENCIA, Calif., & MELBOURNE, Australia AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine company, acknowledges that the company will be added to the S&P/ASX 300 index,...
View ArticleClik here to view.
SpeeDx Receives CE-IVD Clearance for ResistancePlus MG FleXible
SYDNEY SpeeDx Pty, Ltd. today announced ResistancePlus® MG FleXible for the Cepheid GeneXpert® System, detecting the sexually transmitted infection (STI) Mycoplasma genitalium (Mgen) and markers...
View ArticleClik here to view.
IMS Reports the Multidisciplinary Approaches to Minimally Invasive Cancer...
TOKYO Ryusuke Fujiki, Clinical Head and President of Fujiki Hospital, lectured about multidisciplinary approaches which are getting remarkable effect to minimally invasive cancer treatment using JCI...
View ArticleClik here to view.
知临集团已启动用于治疗包括MRSA的金黄色葡萄球菌感染小分子候选药物ALS-4的IND筹备研究
纽约 知临集团（纳斯达克股票代码：APM），一家专注于开发新疗法以解决全球未竟医疗需求的生物制药公司，宣布其已启动针对ALS-4的研究性新药（IND）筹备研究。ALS-4是一种小药物分子候选物，基于新的抗毒力方法以治疗由金黄色葡萄球菌包括耐甲氧西林金黄色葡萄球菌（MRSA，即众所周知的“超级细菌”之一）所引起的感染。...
View ArticleClik here to view.
知臨集団がMRSAを含む黄色ブドウ球菌による感染に対する低分子治療薬候補ALS-4のIND準備研究を開始
ニューヨーク （ビジネスワイヤ） — 世界規模の未充足医療ニーズに対処するための新規治療薬の開発に傾注するバイオ製薬企業の知臨集団（Nasdaq:...
View ArticleClik here to view.
知临集团宣布靶向肥胖症微生物组候选药物和神经母细胞瘤再利用候选药物的开发
纽约 知临集团（纳斯达克股票代码：APM），一家专注于开发新疗法以解决全球未竟医疗需求的生物制药公司，宣布两个临床前候选药物的开发，分别针对肥胖和神经母细胞瘤。 关于CLS-1：通过调节与肠道微生物群相关的化学信号传导以治疗肥胖症 根据最近公布的由知临集团全资子公司Claves Life Sciences...
View ArticleClik here to view.
知臨集団が肥満治療の微生物叢医薬品候補および神経芽細胞腫治療のリパーパシング医薬品候補の開発を発表
ニューヨーク （ビジネスワイヤ） — 世界規模の未充足医療ニーズに対処するための新規治療薬の開発に傾注するバイオテクノロジー企業の知臨集団（NASDAQ：APM）（アプトラム・グループ）は、それぞれ肥満と神経芽細胞腫を対象とする前臨床医薬品候補2種の開発について発表します。 CLS-1について：腸内微生物叢に関係する化学信号の調節による肥満の治療...
View ArticleClik here to view.
Gilead Sciences and the Elton John AIDS Foundation Launch RADIAN Initiative...
LONDON Gilead Sciences, Inc. (Nasdaq: GILD) and the Elton John AIDS Foundation today announced the launch of the ground-breaking RADIAN initiative at the Fast-Track Cities 2019 conference in London....
View ArticleClik here to view.
No Lazy Days of Summer for DKT International
WASHINGTON DKT International, one of the largest private providers of family planning products and services in the developing world, reports a busy summer launching new ads, reducing contraceptive...
View ArticleClik here to view.
宝洁、国家地理和Global Citizen推出开创性系列纪录片《ACTIVATE: THE GLOBAL CITIZEN...
辛辛那提 (美国商业资讯)–宝洁公司(Procter & Gamble)和国家地理频道(National Geographic)共同推出的六集系列纪录片ACTIVATE将于9月5日（周四）即今晚在美国通过国家地理频道首播，ACTIVATE由Global...
View ArticleClik here to view.
P&G、ナショナル ジオグラフィック、グローバル・シチズンが画期的なシリーズ「ACTIVATE: THE GLOBAL CITIZEN...
シンシナティ （ビジネスワイヤ） — プロクター・アンド・ギャンブルとナショナル ジオグラフィックの6回シリーズのドキュメンタリー「ACTIVATE」（共同製作：グローバル・シチズン、ラディカルメディア）の初回が今晩、9月5日木曜日に米国のナショナル...
View ArticleClik here to view.
Samsung Bioepis Continues Global Expansion, Enters Brazilian...
INCHEON, KOREA Samsung Bioepis Co., Ltd. today announced its expansion into the Brazilian biopharmaceutical market. The first product available in the country is BRENZYS™ (etanercept), a biosimilar...
View ArticleClik here to view.
沃博联任命全球首席信息官
伊利诺伊州迪尔菲尔德 (美国商业资讯)–沃博联有限公司(Walgreens Boots Alliance, Inc., Nasdaq: WBA)今天宣布任命Francesco Tinto为全球首席信息官(CIO)兼公司高级副总裁。公司在财富500强中排名第17位，是全球最大的药品零售商和批发商。...
View Article